Effect of a multifaceted quality improvement intervention on the prescription of evidence based treatment in patients at high cardiovascular risk in Brazil The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial
JAMA cardiol. (Online)
; 4(5): 408-417, Mai. 2019. grafico, tabela
Article
in English
| Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP
| ID: biblio-1022826
Responsible library:
BR79.1
Localization: BR79.1
ABSTRACT
RESULTS Of the 1619 included patients,1029 (63.6%) weremale,1327(82.0%) had coronary artery disease (843[52.1%] with prioracutemyo cardial infarction),355(21.9%)had priorischemicstroke ortransientischemicattack,and197 (12.2%) had peripheral vascular disease,andthemean( SD) age was 65.6 (10.5) years. Among randomized clusters, 30 (75%) were cardiology sites, 6 (15%) were primary careunits,and 26 (65%) were teaching institutions.Amonge ligible patients,thosein intervention clusters were more like ly to receive aprescription of evidence-based therapies thant hose in control clusters (73.5%[515of701] vs58.7% [493of840];oddsratio,2.30;95%CI,1.14-4.65). There were no differences between the intervention and control group swithregard storisk factor control(ie,hyperlipidemia,hypertension,ordiabetes).Ratesofeducationforsmokingcessationwere higher among current smokers in the intervention group thanin the control group (51.9%[364of701] vs18.2%[153of840];oddsratio,11.24;95%CI,2.20-57.43).Therateofcardiovascularmortality,acute myocardial infarction,andstrokewas2.6%for patients from intervention cluster sand 3.4%forthose in the control group (hazardratio, 0.76;95%CI,0.43-1.34). (AU)
Search on Google
Collection:
National databases
/
Brazil
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
Sec. Est. Saúde SP
/
SESSP-IDPCPROD
Main subject:
Cardiovascular Diseases
/
Evidence-Based Medicine
/
Disease Prevention
Type of study:
Controlled clinical trial
/
Etiology study
/
Risk factors
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
JAMA cardiol. (Online)
Year:
2019
Document type:
Article
Institution/Affiliation country:
Duke Clinical Research Institute/US
/
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo/BR
/
HCor Hospital do Coração/BR
/
Hospital e Maternidade Celso Pierro/BR
/
Hospital e Maternidade Dr. Christóvão da Gama/BR
/
Instituto Dante Pazzanese de Cardiologia/BR
/
Universidade Federal de São Paulo/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre/BR